Ruxolitinib Response in Teens, Adults With Vitiligo Compared
Pooled data from the phase 3 TRuE-V1 and TRuE-V2 studies were used to evaluate responses in a subset of adolescents treated with the topical JAK inhibitor for vitiligo.
Stay updated with breaking news from Adverse Effects. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pooled data from the phase 3 TRuE-V1 and TRuE-V2 studies were used to evaluate responses in a subset of adolescents treated with the topical JAK inhibitor for vitiligo.
Chile's Atacama Desert boasts the planet's hottest spot, setting world records for solar luminosity, but experts warn of extreme radiation risks. 24.07.2023, Sputnik International
Children and adults with ADHD show greater improvement in symptoms with viloxazine extended release compared with treatment with atomoxetine, new research suggests.
After reports of necrosis at the injection site after the 23-valent pneumococcal vaccine, an FDA investigation has concluded that the benefits of the vaccine outweigh the risks.
Subcutaneous ketamine is a practical, safe, and highly effective way to administer the drug for treatment-resistant depression, results of a randomized controlled phase 3 trial show.